Study of Efficacy and Safety LMF237 in Patients With Type 2 Diabetes Mellitus (T2DM) Inadequately Controlled With Vildagliptin Monotherapy
Clinical trial NCT01811485 · COMPLETED
Trial details
- NCT number
- NCT01811485
- Sponsor
- Novartis Pharmaceuticals
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2013-05-01
- Primary completion
- 2014-02-01
- Enrollment
- 171
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.